Metastatic uveal melanoma complete response with nivolumab: A case report

Abstract

Introduction: Uveal Melanoma (UM) is a rare subtype of melanoma that progresses to metastatic disease in more than 50% of patients [1]. After metastasis develops, the average survival is between 4-15 months [2].